Your browser doesn't support javascript.
loading
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
Kreutzberger, Alex J B; Sanyal, Anwesha; Ojha, Ravi; Pyle, Jesse D; Vapalahti, Olli; Balistreri, Giuseppe; Kirchhausen, Tom.
Afiliação
  • Kreutzberger AJB; Department of Cell Biology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
  • Sanyal A; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Ojha R; Department of Cell Biology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
  • Pyle JD; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Vapalahti O; Department of Virology, Faculty of Medicine, University of Helsinkigrid.7737.4, Helsinki, Finland.
  • Balistreri G; Program in Virology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
  • Kirchhausen T; Department of Virology, Faculty of Medicine, University of Helsinkigrid.7737.4, Helsinki, Finland.
J Virol ; 95(21): e0097521, 2021 10 13.
Article em En | MEDLINE | ID: mdl-34406858

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pirimidinas / Benzamidinas / Serina Endopeptidases / Morfolinas / Fosfatidilinositol 3-Quinases / Ésteres / SARS-CoV-2 / Guanidinas / Hidrazonas Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pirimidinas / Benzamidinas / Serina Endopeptidases / Morfolinas / Fosfatidilinositol 3-Quinases / Ésteres / SARS-CoV-2 / Guanidinas / Hidrazonas Limite: Animals / Humans Idioma: En Revista: J Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos